메뉴 건너뛰기




Volumn 27, Issue 3, 2016, Pages 184-187

Seven key actions to eradicate rheumatic heart disease in Africa: The Addis Ababa communiqu

(48)  Watkins, David a,b   Zuhlke, Liesl a   Engel, Mark a   Daniels, Rezeen a   Francis, Veronica a   Shaboodien, Gasnat a   Kango, Mabvuto c   Abul Fadl, Azza d   Adeoye, Abiodun e   Ali, Sulafa f   Al Kebsi, Mohammed g   Bode Thomas, Fidelia h   Bukhman, Gene i   Damasceno, Albertino j   Goshu, Dejuma Yadeta k   Elghamrawy, Alaa l   Gitura, Bernard m   Haileamlak, Abraham n   Hailu, Abraha o   Hugo Hamman, Christopher p   more..


Author keywords

Prevention; Rheumatic heart disease

Indexed keywords

BENZATHINE PENICILLIN; ANTIINFECTIVE AGENT;

EID: 84979017465     PISSN: 19951892     EISSN: 16800745     Source Type: Journal    
DOI: 10.5830/cvja-2015-090     Document Type: Article
Times cited : (106)

References (20)
  • 1
    • 0022373367 scopus 로고
    • The virtual disappearance of rheumatic fever in the United States: Lessons in the rise and fall of disease. T. Duckett Jones memorial lecture
    • Gordis L. The virtual disappearance of rheumatic fever in the United States: lessons in the rise and fall of disease. T. Duckett Jones memorial lecture. Circulation 1985; 72(6): 1155-1162.
    • (1985) Circulation , vol.72 , Issue.6 , pp. 1155-1162
    • Gordis, L.1
  • 2
    • 57149104593 scopus 로고    scopus 로고
    • Rheumatic heart disease: Social and economic dimensions
    • Robertson KA, Mayosi BM. Rheumatic heart disease: social and economic dimensions. S Afr MedJ 2008; 98(10): 780-781.
    • (2008) S Afr MedJ , vol.98 , Issue.10 , pp. 780-781
    • Robertson, K.A.1    Mayosi, B.M.2
  • 4
    • 33645324405 scopus 로고    scopus 로고
    • Towards a uniform plan for the control of rheumatic fever and rheumatic heart disease in Africa - The Awareness Surveillance Advocacy Prevention (A.S.A.P.) Programme
    • Robertson KA, Volmink JA, Mayosi BM. Towards a uniform plan for the control of rheumatic fever and rheumatic heart disease in Africa - The Awareness Surveillance Advocacy Prevention (A.S.A.P.) Programme. S Afr Med J 2006; 96(3 Pt 2): 241.
    • (2006) S Afr Med J , vol.96 , Issue.3 , pp. 241
    • Robertson, K.A.1    Volmink, J.A.2    Mayosi, B.M.3
  • 5
    • 84884654109 scopus 로고    scopus 로고
    • Rheumatic heart disease back in the limelight
    • Maurice J. Rheumatic heart disease back in the limelight. Lancet 2013; 382(9898): 1085-1086.
    • (2013) Lancet , vol.382 , Issue.9898 , pp. 1085-1086
    • Maurice, J.1
  • 6
    • 84876909245 scopus 로고    scopus 로고
    • Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease
    • World Heart Federation
    • Remenyi B, Carapetis J, Wyber R, Taubert K, Mayosi BM, World Heart Federation. Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease. Nature Rev Cardiol 2013; 10(5): 284-292.
    • (2013) Nature Rev Cardiol , vol.10 , Issue.5 , pp. 284-292
    • Remenyi, B.1    Carapetis, J.2    Wyber, R.3    Taubert, K.4    Mayosi, B.M.5
  • 7
    • 33645315202 scopus 로고    scopus 로고
    • The Drakensberg declaration on the control of rheumatic fever and rheumatic heart disease in Africa
    • Mayosi B, Robertson K, Volmink J, et al. The Drakensberg declaration on the control of rheumatic fever and rheumatic heart disease in Africa. S Afr Med J 2006; 96(3 Pt 2): 246.
    • (2006) S Afr Med J , vol.96 , Issue.3 , pp. 246
    • Mayosi, B.1    Robertson, K.2    Volmink, J.3
  • 8
    • 84904724619 scopus 로고    scopus 로고
    • Rheumatic heart disease in Africa: The Mosi-o-Tunya call to action
    • Mayosi BM, Gamra H, Dangou J-M, Kasonde J. Rheumatic heart disease in Africa: The Mosi-o-Tunya call to action. Lancet Global Health 2014; 2: E438-e439.
    • (2014) Lancet Global Health , vol.2 , pp. e438-e439
    • Mayosi, B.M.1    Gamra, H.2    Dangou, J.-M.3    Kasonde, J.4
  • 9
    • 84929617058 scopus 로고    scopus 로고
    • Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: The Global Rheumatic Heart Disease Registry (the REMEDY study)
    • Zuhlke L, Engel ME, Karthikeyan G, et al. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: The Global Rheumatic Heart Disease Registry (the REMEDY study). Eur Heart J 2015; 36(18): 1115-1122.
    • (2015) Eur Heart J , vol.36 , Issue.18 , pp. 1115-1122
    • Zuhlke, L.1    Engel, M.E.2    Karthikeyan, G.3
  • 12
    • 31844455013 scopus 로고    scopus 로고
    • Death from rheumatic heart disease in rural Ethiopia
    • Gunther G, Asmera J, Parry E. Death from rheumatic heart disease in rural Ethiopia. Lancet 2006; 367(9508): 391.
    • (2006) Lancet , vol.367 , Issue.9508 , pp. 391
    • Gunther, G.1    Asmera, J.2    Parry, E.3
  • 13
    • 84988690832 scopus 로고    scopus 로고
    • The economic impact of rheumatic heart disease in developing countries
    • Watkins D, Daskalakis A. The economic impact of rheumatic heart disease in developing countries. Lancet Global Health 2015; 3: S37.
    • (2015) Lancet Global Health , vol.3 , pp. S37
    • Watkins, D.1    Daskalakis, A.2
  • 14
    • 48249138440 scopus 로고    scopus 로고
    • Prevention and control of rheumatic fever and rheumatic heart disease: The Cuban experience (1986-1996-2002)
    • Nordet P, Lopez R, Duenas A, Sarmiento L. Prevention and control of rheumatic fever and rheumatic heart disease: The Cuban experience (1986-1996-2002). Cardiovasc J Afr 2008; 19(3): 135-140.
    • (2008) Cardiovasc J Afr , vol.19 , Issue.3 , pp. 135-140
    • Nordet, P.1    Lopez, R.2    Duenas, A.3    Sarmiento, L.4
  • 15
    • 0026730530 scopus 로고
    • Prevention of rheumatic fever in Costa Rica
    • Arguedas A, Mohs E. Prevention of rheumatic fever in Costa Rica. J Pediatr 1992; 121(4): 569-572.
    • (1992) J Pediatr , vol.121 , Issue.4 , pp. 569-572
    • Arguedas, A.1    Mohs, E.2
  • 16
    • 22444436593 scopus 로고    scopus 로고
    • Epidemiological transition and health impact of cardiovascular disease in Tunisia
    • Ben Romdhane H, Haouala H, Belhani A, et al. [Epidemiological transition and health impact of cardiovascular disease in Tunisia]. La Tunisie Medicale 2005; 83(Suppl 5): 1-7.
    • (2005) La Tunisie Medicale , vol.83 , pp. 1-7
    • Ben, R.H.1    Haouala, H.2    Belhani, A.3
  • 18
    • 84904972811 scopus 로고    scopus 로고
    • Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
    • Wang H, Liddell CA, Coates MM, et al. Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384(9947): 957-79.
    • (2014) Lancet , vol.384 , Issue.9947 , pp. 957-979
    • Wang, H.1    Liddell, C.A.2    Coates, M.M.3
  • 19
    • 84907272570 scopus 로고    scopus 로고
    • Global, regional, and national levels and causes of maternal mortality during 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
    • Kassebaum NJ, Bertozzi-Villa A, Coggeshall MS, et al. Global, regional, and national levels and causes of maternal mortality during 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384(9947): 980-1004.
    • (2014) Lancet , vol.384 , Issue.9947 , pp. 980-1004
    • Kassebaum, N.J.1    Bertozzi-Villa, A.2    Coggeshall, M.S.3
  • 20
    • 84907348191 scopus 로고    scopus 로고
    • Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
    • Murray CJ, Ortblad KF, Guinovart C, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384(9947): 1005-1070.
    • (2014) Lancet , vol.384 , Issue.9947 , pp. 1005-1070
    • Murray, C.J.1    Ortblad, K.F.2    Guinovart, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.